Brief: Cipher Pharmaceuticals Announces Normal Course Issuer Bid
12/08/2020 23:28
Aug 12 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS ANNOUNCES NORMAL COURSE ISSUER BID
* CIPHER PHARMACEUTICALS INC - CIPHER MAY PURCHASE FOR
CANCELLATION UP TO 1.6 MILLION OF ITS COMMON SHARES
Source text for Eikon: ID:nCNW4zhDba
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million